Analytical Data
-
Gene name
PAX7
- Application
-
Alternative Names
HuP1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P23759
-
Expression Region
1-520 aa
-
AA Sequence
MAALPGTVPRMMRPAPGQNYPRTGFPLEVSTPLGQGRVNQLGGVFINGRPLPNHIRHKIVEMAHHGIRPCVISRQLRVSHGCVSKILCRYQETGSIRPGAIGGSKPRQVATPDVEKKIEEYKRENPGMFSWEIRDRLLKDGHCDRSTVPSGLVSSISRVLRIKFGKKEEEDEADKKEDDGEKKAKHSIDGILGDKGNRLDEGSDVESEPDLPLKRKQRRSRTTFTAEQLEELEKAFERTHYPDIYTREELAQRTKLTEARVQVWFSNRRARWRKQAGANQLAAFNHLLPGGFPPTGMPTLPPYQLPDSTYPTTTISQDGGSTVHRPQPLPPSTMHQGGLAAAAAAADTSSAYGARHSFSSYSDSFMNPAAPSNHMNPVSNGLSPQVMSILGNPSAVPPQPQADFSISPLHGGLDSATSISASCSQRADSIKPGDSLPTSQAYCPPTYSTTGYSVDPVAGYQYGQYGQSECLVPWASPVPIPSPTPRASCLFMESYKVVSGWGMSISQMEKLKSSQMEQFT
-
Molecular Weight
62.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PAX7 is a pivotal member of the paired box (PAX) family of transcription factors, crucial for the regulation of muscle development, satellite cell function, and the maintenance of adult muscle stem cells. Its expression is primarily associated with embryonic muscle precursor cells, where it plays a significant role in myogenesis and the formation of skeletal muscle. Research on PAX7 has gained momentum due to its implications in muscle regeneration and repair, highlighting its potential therapeutic applications in muscle-wasting diseases and injuries. The study of PAX7 recombinant proteins has enabled scientists to delve deeper into its functional properties and biochemical characteristics, facilitating the exploration of its role in signaling pathways and gene expression modulation. Understanding the mechanisms by which PAX7 operates can lead to significant advancements in regenerative medicine and provide insights into genetic muscle disorders. Furthermore, the generation of PAX7 recombinant proteins allows for in vitro and in vivo studies, enhancing our grasp of its regulatory networks in muscle biology. Overall, ongoing research on PAX7 recombinant proteins promises to uncover new avenues for enhancing muscle regeneration and developing therapeutic strategies for muscle-related pathologies.
